Economic Evaluation Of Denosumab Versus Zoledronic Acid (Za) In The Prevention Of Skeletal-Related Events (Sre) In Patients With Prostate Cancer With Bone Metastasis (Bm) In Mexico
May 1, 2013, 00:00
10.1016/j.jval.2013.03.682
https://www.valueinhealthjournal.com/article/S1098-3015(13)00753-5/fulltext
Title :
Economic Evaluation Of Denosumab Versus Zoledronic Acid (Za) In The Prevention Of Skeletal-Related Events (Sre) In Patients With Prostate Cancer With Bone Metastasis (Bm) In Mexico
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00753-5&doi=10.1016/j.jval.2013.03.682
First page :
A139
Section Title :
Cancer
Open access? :
No
Section Order :
228